The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer.

Apoptosis is a crucial biological process that prevents uncontrolled cell proliferation and eliminates harmful cells. Resistance to apoptotic stimuli is a hallmark feature of various cancers. One of the mechanisms through which tumor cells are believed to acquire resistance to apoptosis is by overexpression of inhibitor of apoptosis proteins (IAPs). IAPs are a group of structurally related proteins that were initially identified in baculoviruses. Mammalian IAPs block apoptosis either by binding and inhibiting caspases or through caspase-independent mechanisms. This family of proteins has become increasingly prominent in the field of cancer biology. To date, overexpression of several IAPs has been detected in various cancers. This paper reviews the recent advances in the research of IAPs. The differential expression and the biological significance of each IAP in various cancer types will be discussed. Finally, we review the most recent advances in the research efforts aimed at using IAPs as potential targets for cancer therapy.

[1]  J. McNiff,et al.  Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. , 1999, The Journal of investigative dermatology.

[2]  A. Cesinaro,et al.  Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. , 1999, The Journal of investigative dermatology.

[3]  H. Sung,et al.  Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis. , 2003, Blood.

[4]  T. Chow,et al.  Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death , 2000, Oncogene.

[5]  M. Daidone,et al.  Ribozyme-mediated down-regulation of survivin expression sensitizes human melanoma cells to topotecan in vitro and in vivo. , 2004, Carcinogenesis.

[6]  P. Insel,et al.  Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Mads Hald Andersen,et al.  Identification of Novel Survivin-Derived CTL Epitopes with Different HLA-A-Restriction Profiles , 2004, Cancer biology & therapy.

[8]  S. Nicosia,et al.  Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein (XIAP)* , 2004, Journal of Biological Chemistry.

[9]  Y. Sheng,et al.  Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. , 2000, Cancer research.

[10]  K. Nakanishi,et al.  Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract , 2002, Virchows Archiv.

[11]  Mike Rothe,et al.  The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins , 1995, Cell.

[12]  D. Altieri,et al.  Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. , 1998, Cancer research.

[13]  P. Poma,et al.  Expression of the IAPs in multidrug resistant tumor cells. , 2004, Oncology reports.

[14]  Michael Weller,et al.  Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo , 2002, Nature Medicine.

[15]  K. Shroyer,et al.  Survivin expression in human osteosarcoma is a marker for survival. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  T. Giordano,et al.  Survivin: a novel neuroendocrine marker for pheochromocytoma. , 2002, European journal of endocrinology.

[17]  F. Hoppe-Seyler,et al.  Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene , 2003, Oncogene.

[18]  C. Schamberger,et al.  Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras , 2003, Oncogene.

[19]  V. Bilim,et al.  Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug‐resistant TCC in vitro , 2003, International journal of cancer.

[20]  John Calvin Reed,et al.  Endogenous Inhibitors of Caspases , 1999, Journal of Clinical Immunology.

[21]  O. Mandelboim,et al.  Caspase-mediated cleavage converts Livin from an antiapoptotic to a proapoptotic factor: implications for drug-resistant melanoma. , 2003, Cancer research.

[22]  T. Ueda,et al.  Expression of the antiapoptotic gene survivin in chronic myeloid leukemia. , 2003, Anticancer research.

[23]  J C Reed,et al.  Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  J. Becker,et al.  The melanoma inhibitor of apoptosis protein: a target for spontaneous cytotoxic T cell responses. , 2004, The Journal of investigative dermatology.

[25]  J C Reed,et al.  A Single BIR Domain of XIAP Sufficient for Inhibiting Caspases* , 1998, The Journal of Biological Chemistry.

[26]  M. Ikeguchi,et al.  Expression of Survivin Messenger RNA Correlates With Poor Prognosis in Patients With Hepatocellular Carcinoma , 2002, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[27]  M. Ishikawa,et al.  Analysis of Bcl-2, Bax and Survivin genes in uterine cancer. , 1999, International journal of oncology.

[28]  G. Wood,et al.  Apoptosis and melanoma: molecular mechanisms , 2003, The Journal of pathology.

[29]  C. Kampf,et al.  Increased survivin transcript levels: An independent negative predictor of survival in soft tissue sarcoma patients , 2001, International journal of cancer.

[30]  J. Isenberg,et al.  Cyclic adenosine-3',5'-monophosphate production is greater in rabbit duodenal crypt than in villus cells. , 1996, Scandinavian journal of gastroenterology.

[31]  C. Roehrborn,et al.  Survivin expression is associated with features of biologically aggressive prostate carcinoma , 2004, Cancer.

[32]  Xiao-Ming Yin,et al.  Signal transduction mediated by Bid, a pro-death Bcl-2 family proteins, connects the death receptor and mitochondria apoptosis pathways , 2000, Cell Research.

[33]  R. Korneluk,et al.  The inhibitors of apoptosis: there is more to life than Bcl2 , 2003, Oncogene.

[34]  S. Jentsch,et al.  Deadly encounter: ubiquitin meets apoptosis , 2002, Nature Reviews Molecular Cell Biology.

[35]  H. Shinohara,et al.  Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis , 2001, Cancer.

[36]  M. Tomonaga,et al.  Expression of survivin in HTLV-I-infected T-cell lines and primary ATL cells. , 2001, Biochemical and biophysical research communications.

[37]  Yili Yang,et al.  Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. , 2000, Science.

[38]  C. Kwak,et al.  Expression of survivin, a novel inhibitor of apoptosis, in superficial transitional cell carcinoma of the bladder. , 2004, The Journal of urology.

[39]  S. Florell,et al.  Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression. , 2003, Cancer research.

[40]  K. Tamai,et al.  Identification of XAF1 as an antagonist of XIAP anti-Caspase activity , 2001, Nature Cell Biology.

[41]  John Calvin Reed,et al.  Protein Kinase Inhibitors Flavopiridol and 7-hydroxy-staurosporine Down-regulate Antiapoptosis Proteins in B-cell Chronic Lymphocytic Leukemia , 2022 .

[42]  Jongdae Lee,et al.  IAP Suppression of Apoptosis Involves Distinct Mechanisms: the TAK1/JNK1 Signaling Cascade and Caspase Inhibition , 2002, Molecular and Cellular Biology.

[43]  C. Reed,et al.  Apoptosis and cancer: strategies for integrating programmed cell death. , 2000, Seminars in hematology.

[44]  F. Bosch,et al.  Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. , 2004, The American journal of pathology.

[45]  C. Thompson,et al.  Pathways of Apoptosis in Lymphocyte Development, Homeostasis, and Disease , 2002, Cell.

[46]  A. Vitiello,et al.  Elevated expression of inhibitor of apoptosis proteins in prostate cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[47]  H. Stein,et al.  Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma , 2003, British Journal of Cancer.

[48]  H. Taubert,et al.  Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma , 2002, The Lancet.

[49]  W. Sessa,et al.  Inhibitor of apoptosis protein survivin regulates vascular injury , 2002, Nature Medicine.

[50]  M. Malim,et al.  Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Christian Stehlik,et al.  Activation of NF-κB by XIAP, the X Chromosome-linked Inhibitor of Apoptosis, in Endothelial Cells Involves TAK1* , 2000, The Journal of Biological Chemistry.

[52]  Xuebiao Yao,et al.  Direct Interaction between Survivin and Smac/DIABLO Is Essential for the Anti-apoptotic Activity of Survivin during Taxol-induced Apoptosis* , 2003, Journal of Biological Chemistry.

[53]  K. McEleny,et al.  Inhibitors of apoptosis proteins in prostate cancer cell lines , 2002, The Prostate.

[54]  R. Weiss,et al.  Urine detection of survivin and diagnosis of bladder cancer. , 2001, JAMA.

[55]  Boris Zhivotovsky,et al.  Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells. , 2002, Experimental cell research.

[56]  A. Lin.  Activation of the JNK signaling pathway: Breaking the brake on apoptosis , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[57]  C. Schmitt.  Senescence, apoptosis and therapy — cutting the lifelines of cancer , 2003, Nature Reviews Cancer.

[58]  G. Gores,et al.  Synthetic Smac/DIABLO Peptides Enhance the Effects of Chemotherapeutic Agents by Binding XIAP and cIAP1 in Situ * , 2002, The Journal of Biological Chemistry.

[59]  B. Boman,et al.  Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. , 2001, Cancer research.

[60]  K. Hirata,et al.  Detection of anti-livin antibody in gastrointestinal cancer patients. , 2001, Clinical chemistry.

[61]  E. Rieber,et al.  Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients. , 2000, Cancer research.

[62]  J. M. Kim,et al.  Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. , 2001, Endocrinology.

[63]  S. Srinivasula,et al.  Structural Basis of Caspase-7 Inhibition by XIAP , 2001, Cell.

[64]  M. Mutoh,et al.  Expression of the anti-apoptotic gene survivin in myelodysplastic syndrome. , 2003, International journal of oncology.

[65]  P. Black,et al.  Quantitatively determined survivin expression levels are of prognostic value in human gliomas. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  Jiandong Chen,et al.  Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53* , 2002, The Journal of Biological Chemistry.

[67]  T. Hashikawa,et al.  Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways , 2004, Cell Death and Differentiation.

[68]  D. Schadendorf,et al.  Drug‐resistance in human melanoma , 2001, International journal of cancer.

[69]  Young Chul Park,et al.  Structural Basis of Caspase Inhibition by XIAP Differential Roles of the Linker versus the BIR Domain , 2001, Cell.

[70]  J C Reed,et al.  Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases , 1999, The EMBO journal.

[71]  R. Silber,et al.  Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer , 2002, Journal of Cancer Research and Clinical Oncology.

[72]  R. Weiss,et al.  Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. , 1999, New England Journal of Medicine.

[73]  Y. Kameda,et al.  Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung. , 2002, Oncology reports.

[74]  G. Cohen,et al.  Proteasome-mediated Degradation of Smac during Apoptosis: XIAP Promotes Smac Ubiquitination in Vitro * , 2002, The Journal of Biological Chemistry.

[75]  P. Marynen,et al.  The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. , 1999, Blood.

[76]  Min Chen,et al.  Initiator caspases in apoptosis signaling pathways , 2002, Apoptosis.

[77]  C. Duckett,et al.  c-IAP1 Is Cleaved by Caspases to Produce a Proapoptotic C-terminal Fragment* , 2001, The Journal of Biological Chemistry.

[78]  S. Moriyama,et al.  Expression of survivin in esophageal cancer: Correlation with the prognosis and response to chemotherapy , 2001, International journal of cancer.

[79]  R. Liddington,et al.  Structural Basis for the Inhibition of Caspase-3 by XIAP , 2001, Cell.

[80]  T. Gasser,et al.  Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. , 2004, The Journal of urology.

[81]  M. Ikeguchi,et al.  survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma , 2002, British Journal of Cancer.

[82]  D. B. Yehuda,et al.  Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern , 2001, FEBS letters.

[83]  M. Andreeff,et al.  Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia , 2003, Leukemia.

[84]  D. Altieri,et al.  Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. , 1998, Cancer research.

[85]  J. McNiff,et al.  Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[86]  A. Harvey,et al.  Anti- and pro-apoptotic activities of baculovirus and Drosophila IAPs in an insect cell line , 1997, Cell Death and Differentiation.

[87]  M. Distefano,et al.  Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP). , 2003, Biochemistry.

[88]  L. Kiemeney,et al.  Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. , 2003, Anticancer research.

[89]  Naoto Ueno,et al.  XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1–TAK1 in the BMP signaling pathway , 1999, The EMBO journal.

[90]  D. Altieri,et al.  A p34(cdc2) survival checkpoint in cancer. , 2002, Cancer cell.

[91]  P. Krammer,et al.  Apoptosis in cancer--implications for therapy. , 2004, Seminars in oncology.

[92]  V. Dragowska,et al.  Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[93]  G. Giaccone,et al.  Expression of X-linked inhibitor of apoptosis as a novel prognostic marker in radically resected non-small cell lung cancer patients. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[94]  S. Ansell,et al.  Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma , 2004, Leukemia.

[95]  L. O’Driscoll,et al.  Prognostic importance of survivin in breast cancer , 2003, British Journal of Cancer.

[96]  K. Shroyer,et al.  Survivin in glioblastomas. Protein and messenger RNA expression and comparison with telomerase levels. , 2003, Archives of pathology & laboratory medicine.

[97]  A. Masamune,et al.  Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors , 2001, Cancer.

[98]  J. Ross,et al.  Survivin and Bcl-2 expression in prostatic adenocarcinomas. , 2009, Archives of pathology & laboratory medicine.

[99]  R. Livingston,et al.  Lung Cancer 1 , 1981, Cancer Treatment and Research.

[100]  L. Tian,et al.  Cisplatin resistance in an ovarian carcinoma is associated with a defect in programmed cell death control through XIAP regulation. , 2003, Oncology research.

[101]  N. Takai,et al.  Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma. , 2002, International journal of molecular medicine.

[102]  Yasuo Watanabe,et al.  Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors. , 2002, International journal of oncology.

[103]  E. Asselin,et al.  Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1. , 2003, International journal of oncology.

[104]  R. Rosell,et al.  The anti-apoptosis survivin gene and its role in human cancer: an overview. , 1999, Clinical lung cancer.

[105]  I. Herr,et al.  Cellular stress response and apoptosis in cancer therapy. , 2001, Blood.

[106]  Christian Stehlik,et al.  Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced Apoptosis , 1998, The Journal of experimental medicine.

[107]  W. R. Bishop,et al.  Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway , 2002, Oncogene.

[108]  G. Giaccone,et al.  Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[109]  F. Moatamed,et al.  Excessive survivin expression in thyroid lymphomas. , 2002, Human pathology.

[110]  J Diebold,et al.  Prognostic significance of survivin expression in diffuse large B-cell lymphomas. , 2000, Blood.

[111]  J. Li,et al.  Cancer gene therapy using a survivin mutant adenovirus. , 2001, The Journal of clinical investigation.

[112]  O. Ishiko,et al.  Survivin, bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas. , 2001, International journal of oncology.

[113]  M. Daidone,et al.  Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer , 2002, Cellular and Molecular Life Sciences CMLS.

[114]  J. Becker,et al.  HLA‐B35‐restricted immune responses against survivin in cancer patients , 2004, International journal of cancer.

[115]  E. Felip,et al.  A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[116]  L. Frati,et al.  Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[117]  R. Takahashi,et al.  Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[118]  Geng Wu,et al.  Structural basis of IAP recognition by Smac/DIABLO , 2000, Nature.

[119]  R. Glas,et al.  Tumors Acquire Inhibitor of Apoptosis Protein (IAP)-mediated Apoptosis Resistance through Altered Specificity of Cytosolic Proteolysis , 2003, The Journal of experimental medicine.

[120]  S. Lowe,et al.  Control of apoptosis by p53 , 2003, Oncogene.

[121]  Mark P. Mattson,et al.  Apoptosis in neurodegenerative disorders , 2000, Nature Reviews Molecular Cell Biology.

[122]  Yuri Lazebnik,et al.  Identification of Omi/HtrA2 as a Mitochondrial Apoptotic Serine Protease That Disrupts Inhibitor of Apoptosis Protein-Caspase Interaction* , 2002, The Journal of Biological Chemistry.

[123]  C. Cohen,et al.  Survivin Expression in Ovarian Carcinoma: Correlation with Apoptotic Markers and Prognosis , 2003, Modern Pathology.

[124]  N. Sonenberg,et al.  Internal ribosome initiation of translation and the control of cell death. , 2000, Trends in genetics : TIG.

[125]  H. Nakayama,et al.  A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. , 2001, Molecular cell.

[126]  S. Hamilton-Dutoit,et al.  XIAP-mediated Caspase Inhibition in Hodgkin's Lymphoma–derived B Cells , 2003, The Journal of experimental medicine.

[127]  Clemencia Pinilla,et al.  Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. , 2004, Cancer cell.

[128]  Y. Pommier,et al.  Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis. , 2003, Cancer research.

[129]  L. Frati,et al.  Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[130]  D. Altieri,et al.  A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.

[131]  Fengzhi Li,et al.  Pleiotropic cell-division defects and apoptosis induced by interference with survivin function , 1999, Nature Cell Biology.

[132]  S. Lowe,et al.  Apoptosis and melanoma chemoresistance , 2003, Oncogene.

[133]  F. Sigaux,et al.  Expression and prognostic significance of survivin in de novo acute myeloid leukaemia , 2000, British journal of haematology.

[134]  P. Schultz,et al.  Development and characterization of nonpeptidic small molecule inhibitors of the XIAP/caspase-3 interaction. , 2003, Chemistry & biology.

[135]  B. Mark Evers,et al.  Induction of cIAP-2 in Human Colon Cancer Cells through PKCδ/NF-κB* , 2003, Journal of Biological Chemistry.

[136]  A. Marchetti,et al.  Survivin gene expression in early‐stage non‐small cell lung cancer , 2003, The Journal of pathology.

[137]  K. Tanriverdi,et al.  Survivin and aven: two distinct antiapoptotic signals in acute leukemias. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[138]  M J Clemens,et al.  Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells , 2000, Cell Death and Differentiation.

[139]  Takashi Tsuruo,et al.  Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. , 2003, Cancer research.

[140]  M. Lucia,et al.  Immunohistochemical Localization of the IAP Protein Survivin in Bladder Mucosa and Transitional Cell Carcinoma , 2002, Applied immunohistochemistry & molecular morphology : AIMM.

[141]  M. Karin,et al.  Inhibition of JNK activation through NF-κB target genes , 2001, Nature.

[142]  M. Ikeguchi,et al.  Survivin Gene Expression Positively Correlates with Proliferative Activity of Cancer Cells in Esophageal Cancer , 2003, Tumor Biology.